Core Viewpoint - Haocen Medical (002622.SZ) is forecasting a significant loss for the fiscal year 2025, with net profit attributable to shareholders expected to be between a loss of 70 million to 140 million yuan, compared to a loss of 37.69 million yuan in the same period last year [1] Financial Performance - The company anticipates a net loss of 65 million to 130 million yuan after excluding non-recurring gains and losses, compared to a loss of 23.88 million yuan in the previous year [1] - The overall performance for 2025 is expected to be negatively impacted by increased market competition and rising customer acquisition costs in the dental service sector [1] Business Challenges - The dental service business has experienced a significant decline in profitability compared to the previous year due to intensified market competition and a substantial decrease in average customer spending [1] - The company plans to conduct impairment tests on goodwill and long-term equity investments, anticipating that some investments will have recoverable amounts lower than their book values, leading to additional impairment provisions [1]
皓宸医疗(002622.SZ):预计2025年净亏损7000万元-1.40亿元